Galvez, Janaya M.
HRN: 20-22-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/12/2023
03/19/2023
IV
660mg
Q6hours
PCAP-D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes